Aflac (AFL) Getting Somewhat Positive News Coverage, Analysis Shows

Headlines about Aflac (NYSE:AFL) have been trending somewhat positive on Monday, Accern Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aflac earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 44.8383222312944 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the news stories that may have effected Accern’s rankings:

How to Become a New Pot Stock Millionaire

Shares of NYSE:AFL traded up $0.21 during trading on Monday, hitting $44.77. 2,940,796 shares of the company’s stock traded hands, compared to its average volume of 4,758,922. Aflac has a 52 week low of $36.40 and a 52 week high of $45.88. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.05 and a quick ratio of 0.05. The stock has a market capitalization of $34,728.55, a PE ratio of 13.17, a price-to-earnings-growth ratio of 1.75 and a beta of 0.95.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $0.80 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.02. Aflac had a return on equity of 12.29% and a net margin of 20.18%. The business had revenue of $5.42 billion for the quarter, compared to analysts’ expectations of $5.44 billion. During the same quarter in the previous year, the business posted $0.72 EPS. Aflac’s revenue for the quarter was down 8.9% on a year-over-year basis. research analysts expect that Aflac will post 3.89 earnings per share for the current year.

AFL has been the topic of a number of recent analyst reports. JPMorgan Chase reduced their target price on Aflac to $47.00 and set an “overweight” rating on the stock in a report on Tuesday, March 27th. Zacks Investment Research upgraded Aflac from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a report on Tuesday, April 3rd. Janney Montgomery Scott restated a “buy” rating on shares of Aflac in a report on Tuesday, January 16th. Wells Fargo restated a “market perform” rating and set a $45.00 target price (up previously from $42.00) on shares of Aflac in a report on Tuesday, January 9th. Finally, ValuEngine upgraded Aflac from a “buy” rating to a “strong-buy” rating in a report on Friday, February 2nd. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating, four have given a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $44.68.

In other news, Director Joseph L. Moskowitz bought 550 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were purchased at an average price of $89.13 per share, for a total transaction of $49,021.50. Following the purchase, the director now owns 9,263 shares of the company’s stock, valued at approximately $825,611.19. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider June P. Howard sold 2,648 shares of the business’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $90.33, for a total value of $239,193.84. The disclosure for this sale can be found here. Insiders have sold a total of 37,631 shares of company stock worth $2,919,118 in the last quarter. 1.70% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: This article was posted by Week Herald and is the property of of Week Herald. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at

Aflac Company Profile

Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Insider Buying and Selling by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with's FREE daily email newsletter.

Leave a Reply